| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |